We offer biopharmaceutical services tailored to suit your R&D projects as well as face your solubility challenges with your API.
Marinomed Biotech AG provides Solv4U technology partnerships which address solubility and bioavailability issues and supports formulation development of both well-established API’s and new chemical entities (NCE’s), in all stages of drug development, based on its proprietary innovative Marinosolv® technology platform.
Dr. Cornelia Siegl
Head Solv4U